Viewing Study NCT07128693


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2025-12-30 @ 7:37 PM
Study NCT ID: NCT07128693
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-19
First Post: 2025-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma
Sponsor: The First Affiliated Hospital of Zhengzhou University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module